Structure, Function, and Applications of the Georgetown–Einstein (GE) Breast Cancer Simulation Model

Common Model Inputs Used in CISNET Collaborative Breast Cancer Modeling

(2018) Jeanne S. Mandelblatt et al.   MEDICAL DECISION MAKING

Collaborative Modeling of the Benefits and Harms Associated With Different U.S. Breast Cancer Screening Strategies

(2016) Jeanne S. Mandelblatt et al.   ANNALS OF INTERNAL MEDICINE

Transition From Film to Digital Mammography

(2015) Nicolien T. van Ravesteyn et al.   AMERICAN JOURNAL OF PREVENTIVE MEDICINE

Benefits, Harms, and Cost-Effectiveness of Supplemental Ultrasonography Screening for Women With Dense Breasts

(2015) Brian L. Sprague et al.   ANNALS OF INTERNAL MEDICINE

The Contribution of Mammography Screening to Breast Cancer Incidence Trends in the United States: An Updated Age-Period-Cohort Model

(2015) R. E. Gangnon et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Personalizing Age of Cancer Screening Cessation Based on Comorbid Conditions: Model Estimates of Harms and Benefits

(2014) Iris Lansdorp-Vogelaar et al.   ANNALS OF INTERNAL MEDICINE

Effects of Mammography Screening Under Different Screening Schedules: Model Estimates of Potential Benefits and Harms

(2013) Jeanne S. Mandelblatt   ANNALS OF INTERNAL MEDICINE

Screening for Breast Cancer: U.S. Preventive Services Task Force Recommendation Statement

(2013)   ANNALS OF INTERNAL MEDICINE

Tipping the Balance of Benefits and Harms to Favor Screening Mammography Starting at Age 40 Years

(2013) Nicolien T. van Ravesteyn   ANNALS OF INTERNAL MEDICINE

Which strategies reduce breast cancer mortality most?

(2013) Jeanne Mandelblatt et al.   CANCER

Collaborative modeling of the impact of obesity on race-specific breast cancer incidence and mortality

(2012) Yaojen Chang et al.   BREAST CANCER RESEARCH AND TREATMENT

Modeling Good Research Practices—Overview

(2012) J. Jaime Caro et al.   MEDICAL DECISION MAKING

Race-Specific Impact of Natural History, Mammography Screening, and Adjuvant Treatment on Breast Cancer Mortality Rates in the United States

(2011) N. T. van Ravesteyn et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION